Astute Investors Are Taking a Second Look at Haemonetics Corporation (NYSE:HAE)

Shares of Haemonetics Corporation (NYSE:HAE) are on our watchlist today as the stock has moved 0.09% from the open, touching $68.84 on a recent trade. While the stock has a nice low price tag to it, does it have any value?

Equity markets can move in an instant, requiring investors to always stay on their toes. Most sudden stock spikes or drops require the attention of anyone who is keeping a keen eye on the shares. What may go somewhat undetected is the slow and steady rise or fall of a particular stock. Sometimes it can be difficult to decipher fact from fiction in the markets. Why is a company that consistently produces strong returns going down? Why are the underperforming company shares moving higher? While there may be no clear cut answers to the questions, professional investors work endlessly to make sense of equity market nuances.

Based on recent analysis, Haemonetics Corporation (NYSE:HAE) shares have been seen trading -4.83% off of the 50-day peak and 23.28% away from the 50-day bottom. In terms of the stock price in relation to its moving averages, company shares are 5.12% away from the 20-day moving average and 11.66% off of the 50-day average. If we take a longer approach, shares have been trading 42.81% away from the 200-day moving average.

Occasionally investors may be looking to shift their stock strategy. Maybe one plan worked for a period of time, but now economic conditions have shifted and a change is required. Whatever the case, the primary goal is typically to maximize profits. Finding a winning investing strategy may not happen immediately. Navigating the sometimes murky economic waters can be a struggle. Staying afloat may depend on many factors, but doing homework and studying all the available information is essential.

Over the last year, Haemonetics Corporation (NYSE:HAE)’s stock has performed 82.94%. For the last six months, the stock has performed 61.98%. From the start of the calendar year, shares have been 18.53%. Zooming in closer, company stock has been 25.35% for the quarter, 6.30% over the past month, and 13.37% over the past week.

RETURNS AND RECOMMENDATIONS

Pulling back the curtain on Haemonetics Corporation’s Return on Assets (ROA), we note that they currently have 0.30% ROA, which is an indicator of how profitable they are relative to their total assets.  ROA lets us know how efficient management is.  ROA is calculated by dividing annual earnings by total assets.  Haemonetics Corporation’s Return on Equity (ROE) is 0.50%, revealing how much profit they generate with shareholder’s money.  ROE is calculated by dividing net income by shareholder’s equity.  Haemonetics Corporation’s Return on Investment (ROI), a measure used to evaluate the stock’s efficiency, calculated by the return of an investment divided by the cost, is -1.70%. 

Analysts recommend 2.30 on this stock on a consensus basis (1-5 scale).  These are sell-side experts who dedicate their career covering specific stocks.